By Dominic Chopping


STOCKHOLM--Swedish private-equity firm Nordic Capital said Monday it has agreed to sell specialty diagnostics company The Binding Site to Thermo Fisher Scientific Inc. in a deal valued at 2.25 billion pounds ($2.61 billion).

Nordic Capital has been the majority owner of The Binding Site since 2011 when it completed the acquisition together with Five Arrows, the alternative assets arm of Rothschild & Co.

Nordic Capital and Five Arrows have now entered a definitive agreement to sell The Binding Site, with the deal expected to be completed in the first half of 2023, subject to closing conditions.


Write to Dominic Chopping at dominic.chopping@wsj.com


(END) Dow Jones Newswires

10-31-22 0802ET